Company Filing History:
3 out of 197 
1 out of 832,843 Years Active: 2001-2003
Title: The Innovative Contributions of Ryan Holcomb
Introduction
Ryan Holcomb is a notable inventor based in San Carlos, California. He has made significant contributions to the field of biotechnology, particularly in the development of telomerase inhibitors. With a total of four patents to his name, Holcomb's work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Holcomb's latest patents focus on telomerase inhibitors and methods of their use. These include thiazolidinedione compounds, compositions, and methods for inhibiting telomerase activity both in vitro and in vivo. The inventions provide methods, compounds, and compositions that can be used alone or in combination with other pharmacologically active agents to treat conditions mediated by telomerase activity. Additionally, novel methods for assaying or screening for inhibitors of telomerase activity are disclosed in his patents.
Career Highlights
Throughout his career, Ryan Holcomb has worked with prominent organizations, including Geron Corporation. His innovative research has positioned him as a key figure in the biotechnology sector, particularly in the realm of cancer treatment.
Collaborations
Holcomb has collaborated with notable colleagues such as Richard L. Tolman and Allison C. Chin. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Ryan Holcomb's contributions to biotechnology, particularly through his patents on telomerase inhibitors, showcase his innovative spirit and dedication to advancing medical science. His work holds promise for improving treatment options for serious diseases, making him a significant figure in the field.